Hussain, M. et al. 2021. COMPARISON OF EFFICACY AND SAFETY PROFILE OF EMPAGLIFLOZIN VERSUS DAPAGLIFLOZIN AS ADD ON THERAPY IN TYPE 2 DIABETIC PATIENTS. Journal of Ayub Medical College Abbottabad. 33, 4 (Oct. 2021), 593–597.